SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-005720
Filing Date
2017-09-26
Accepted
2017-09-26 10:40:18
Documents
24
Period of Report
2017-09-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_092617.htm 8-K 12091
2 EXHIBIT 99.1 exh_991.htm EX-99.1 31883
3 GRAPHIC image_001.jpg GRAPHIC 66862
4 GRAPHIC image_002.jpg GRAPHIC 98457
5 GRAPHIC image_003.jpg GRAPHIC 126371
6 GRAPHIC image_004.jpg GRAPHIC 70248
7 GRAPHIC image_005.jpg GRAPHIC 53695
8 GRAPHIC image_006.jpg GRAPHIC 85881
9 GRAPHIC image_007.jpg GRAPHIC 84321
10 GRAPHIC image_008.jpg GRAPHIC 63475
11 GRAPHIC image_009.jpg GRAPHIC 71832
12 GRAPHIC image_010.jpg GRAPHIC 75202
13 GRAPHIC image_011.jpg GRAPHIC 73124
14 GRAPHIC image_012.jpg GRAPHIC 61816
15 GRAPHIC image_013.jpg GRAPHIC 65191
16 GRAPHIC image_014.jpg GRAPHIC 48842
17 GRAPHIC image_015.jpg GRAPHIC 48947
18 GRAPHIC image_016.jpg GRAPHIC 87456
19 GRAPHIC image_017.jpg GRAPHIC 83081
20 GRAPHIC image_018.jpg GRAPHIC 55342
21 GRAPHIC image_019.jpg GRAPHIC 53277
22 GRAPHIC image_020.jpg GRAPHIC 65868
23 GRAPHIC image_021.jpg GRAPHIC 51113
24 GRAPHIC image_022.jpg GRAPHIC 69738
  Complete submission text file 0001171843-17-005720.txt   2183008
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 171101173
SIC: 2834 Pharmaceutical Preparations